Provided by Tiger Trade Technology Pte. Ltd.

Indaptus Therapeutics, Inc.

2.30
-0.5500-19.30%
Post-market: 2.28-0.0183-0.80%19:31 EDT
Volume:643.11K
Turnover:1.56M
Market Cap:305.90M
PE:-4.88
High:2.91
Open:2.87
Low:2.26
Close:2.85
52wk High:5.96
52wk Low:0.9200
Shares:133.00M
Float Shares:23.24M
Volume Ratio:1.11
T/O Rate:2.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4709
EPS(LYR):-21.5800
ROE:-318.04%
ROA:-98.08%
PB:26.90
PE(LYR):-0.11

Loading ...

Indaptus Therapeutics Extends Deadline for USD 24 Million Private Placement Closing to Oct. 16

Reuters
·
Yesterday

Indaptus Therapeutics - Enters Stock Purchase Agreement on Sept 8, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 10

Indaptus Therapeutics - to Issue 20,338,974 Shares for Gross Proceeds of $24 Mln - SEC Filing

THOMSON REUTERS
·
Sep 10

Indaptus Therapeutics Prices USD 24 Million Private Placement of 20,338,974 Shares

Reuters
·
Sep 10

Indaptus Amends 8-K to Update Dilution Disclosure in ATM Prospectus Supplement

Reuters
·
Sep 08

Indaptus Therapeutics Director Tim Ruan Resigns from Board

Reuters
·
Sep 05

Indaptus Therapeutics Enters Amended ATM Equity Distribution Agreement for up to $100 Million Common Stock Offering

Reuters
·
Sep 01

Indaptus Therapeutics Inc: Files for Offering of up to $100 Mln Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
Aug 31

Indaptus Therapeutics - Proposed Resale of up to 58,895,000 Shares of Common Stock by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Aug 18

Indaptus Q2 Net Loss Narrows as Costs Fall

Reuters
·
Aug 13

Indaptus Therapeutics Q2 EPS USD -0.02

THOMSON REUTERS
·
Aug 13

Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Aug 13

Insider Traders Lose US$34k As Indaptus Therapeutics Drops

Simply Wall St.
·
Jul 08

Indaptus Therapeutics Inc - Files for Resale by the Selling Stockholders of up to 18.86 Mln Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
Jun 27

Indaptus Therapeutics - to Issue 20 Mln Shares at $0.6 Per Share - SEC Filing

THOMSON REUTERS
·
Jun 25

Indaptus Therapeutics - Private Placement Gross Proceeds About $12 Mln Before Expenses - SEC Filing

THOMSON REUTERS
·
Jun 25

Indaptus Therapeutics Sells 20,000,000 Shares at $0.6 in $12 Million Private Placement

Reuters
·
Jun 25

Top Premarket Decliners

MT Newswires Live
·
Jun 05

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:47 PM

Reuters
·
Jun 05

Indaptus Therapeutics Q1 net loss narrows as expenses fall

Reuters
·
May 15